Lateral Ridge Augmentation Using Autogenous Bone Blocks or Xenogenic Bone Block Grafts Loaded With Recombinant Human Bone Morphogenic Protein 2

Inclusion Criteria: * requiring implant therapy for the reconstruction of 1 to 4 missing teeth * revealing insufficient bone volume for implant placement (cases where less than 50% of the implant surface would be surrounded by native bone) requiring bone augmentation procedure Exclusion Criteria: * Medication with a contraindication for implant therapy * Previous administration of InductOs * Skeletal immaturity * Any active malignancy or patient undergoing treatment for a malignancy * An active infection at the operative site * Persistent compartment syndrome or neurovascular residua of compartment syndrome * Pathological fractures such as those observed in (but not limited to) Paget's disease or in metastatic bone * Contraindications to the class of drugs under study, e.g. known hypersensitivity or allergy to class of drugs or the investigational product, * Contraindications on ethical grounds, * Pregnancy, * Intention to become pregnant during the course of the study, * Breast feeding, * Treatment with other investigational products, * Other clinically significant concomitant disease states (e.g., renal failure, hepatic dysfunction, cardiovascular disease, etc), * Known or suspected non-compliance, drug or alcohol abuse, * Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia or confusional state of the subject, * Participation in another study with investigational drug within the 30 days preceding and during the present study, * Previous enrolment into the current study, * Enrolment of the investigator, his/her family members, employees and other dependent persons, * Patients where autogenous bone cannot be harvested.